查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1969153

液态医用黏合剂市场：依产品类型、应用、最终用户、通路划分，全球预测（2026-2032年）

Liquid Medical Adhesives Market by Product Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

液体医疗用黏合剂市场は、2025年に122亿9,000万米ドルと评価され、2026年には131亿2,000万米ドルに成长し、CAGR 7.35％で推移し、2032年までに202亿1,000万米ドルに达すると予测されています。

主要市场统计数据
基准年 2025 122.9亿美元
预计年份：2026年 131.2亿美元
预测年份 2032 202.1亿美元
复合年增长率 (%) 7.35%

了解聚合物化学的进步和临床重点如何重新定义液体医用黏合剂在整个护理路径和整个医疗设备生态系统中的作用。

液态医用黏合剂正逐渐成为现代医疗流程中一项至关重要的基础技术，弥合了医疗设备设计、伤口管理和以病人为中心的照护之间的鸿沟。这些化学技术能够实现快速黏合、与皮肤和医用基材的强力黏合，并具有生物相容性，使其成为对无缝线闭合、医疗设备固定和牢固的可穿戴介面至关重要的应用的理想选择。聚合物科学、表面化学和黏合剂固化製程的进步拓展了其功能，即使在潮湿环境、移动条件和长期配戴条件下，也能确保可靠的黏合性能。

了解材料创新、临床工作流程的演变和永续性这三种力量的融合，以重建满足现代医学需求的液态医用黏合剂。

液态医用黏合剂领域正经历着一场变革，其驱动力包括技术创新、临床工作流程的演变以及患者期望的不断提高。包括更先进的丙烯酸酯、氰基丙烯酸酯衍生物和硅酮配方在内的新型化学技术，使得黏合剂能够兼具即时固定和温和移除的特性，从而拓展了其在敏感肌肤和慢性伤口患者中的应用范围。同时，与智慧型穿戴装置和药物输送贴片的整合也对黏合剂，例如保持感测器的精确度、透气性和可控的配戴时间。

本检验了近期美国关税调整如何促使整个黏合剂价值链进行策略性采购转移、成本控制措施和弹性规划。

美国近期关税政策的变化和贸易政策决策为原材料和成品黏合剂供应商带来了新的商业风险和营运复杂性。关税调整影响上游聚合物供应商、特殊单体生产商以及底漆和包装材料等辅助组件。因此，采购部门正在重新评估其筹资策略，包括近岸外包、多供应商认证和重新谈判框架协议，以缓解利润压力和交货不确定性。

在液态医用黏合剂领域创造差异化机会：探索产品化学、临床应用、终端用户优先事项和通路的交集。

市场区隔揭示了临床需求、材料性能和分销物流的交汇点，从而创造了差异化机会。基于产品类型的创新优先开发具有广泛黏合性能的丙烯酸酯黏合剂、用于快速组织黏合的氰基丙烯酸酯黏合剂、适用于伤口渗出液管理的亲水胶体黏合剂、具有优异延展性和耐久性的聚氨酯黏合剂，以及对皮肤温和且提供卓越长期舒适度的硅酮黏合剂。这些材料特性会影响配方路线，使每种产品类型都能针对其最佳应用进行最佳化。

我们将评估美洲、欧洲、中东和非洲以及亚太地区的区域管理体制、医疗保健基础设施和采购政策如何影响产品引进和商业化策略。

区域趋势凸显了管理体制、医疗基础设施和在地采购趋势如何驱动不同管道的采用。在美洲，先进的医院系统、高门诊量以及对居家医疗日益增长的重视正在塑造市场需求。在这种环境下，那些在缩短治疗时间和提高患者舒适度方面展现出明显临床优势的黏合剂更具优势，而商业模式往往强调与医疗服务提供者的直接合作以及集中式分销网络。

该评估旨在评估材料创新、监管专业知识和策略伙伴关係如何创造液态医用黏合剂领域的竞争优势和领导地位。

医疗设备原始设备製造商 (OEM)、特殊黏合剂製造商和契约製造组织 (CMO) 之间的材料创新、垂直整合和策略联盟的整合，共同塑造了当前的竞争格局。主要企业凭藉其专有的化学技术脱颖而出，这些技术能够平衡黏合强度和皮肤亲和性；此外，它们还拥有高效的生产平台，确保产品品质的稳定性；同时，它们也具备丰富的法规遵从经验，能够加速临床应用。与医疗设备製造商和临床研究合作伙伴建立策略联盟的情况日益普遍，这使得企业能够共同开发整合式黏合剂和医疗设备，以及针对特定应用的证据包。

为了在利用黏合剂的医疗应用领域实现永续成长，必须采取切实可行的蓝图，将材料创新、强大的采购系统和加速的临床检验相结合。

领导企业应优先采取三管齐下的策略：材料和使用者体验创新、增强供应链韧性以及加快临床检验。投资于兼具强黏合性和微创移除能力的先进化学技术，将有助于应对最紧迫的临床挑战，并开拓新的应用领域。同时，设计中应考虑透气性、低致敏性和感测器相容性等以患者为中心的因素，以确保产品在从门诊护理到居家医疗等各种环境下都能可靠使用。

了解我们如何透过结合技术文献、监管分析和相关人员访谈的多源调查方法，对黏合剂产业进行稳健且可重复的评估。

本分析的研究结合了对公开科学文献、监管文件和专利概况的系统性回顾，以及对整个黏合剂和医疗设备生态系统的结构化访谈和基于一手资料的讨论。技术文献提供了有关聚合物化学、固化机制和生物相容性测试标准的背景信息，而监管文件则阐明了主要司法管辖区的核准流程和上市后监管要求。

为了最大限度地发挥液态医用黏合剂的潜力，我们整合了技术卓越性、临床证据和稳健营运必须协同运作的策略要求。

液态医用黏合剂有望在现代医学中发挥日益重要的作用，实现无缝合、牢固的医疗设备固定以及舒适易用的佩戴式介面。材料科学的进步，加上临床应用模式的不断扩展，正推动其在导管固定、药物传输贴片、电极固定、造口装置和外科性创伤闭合等诸多领域中广泛应用。同时，随着终端使用者转向门诊和居家医疗，对能够在传统临床环境之外可靠发挥作用的黏合剂的需求也日益增长。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 液态医用黏合剂市场：依产品类型划分

  • 丙烯酸黏合剂
  • 氰基丙烯酸黏合剂
  • 亲水胶体黏合剂
  • 聚氨酯黏合剂
  • 硅胶黏合剂

第九章 液态医用黏合剂市场：依应用领域划分

  • 导管固定
  • 药物输送贴片
  • 固定电极
  • 造口用品
  • 外科性创伤闭合

第十章 液态医用黏合剂市场：依最终用户划分

  • 门诊手术中心
  • 居家医疗
  • 医院和诊所
  • 研究所

第十一章 液态医用黏合剂市场：按分销管道划分

  • 直销
  • 销售代理
  • 线上销售

第十二章 液态医用黏合剂市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 液态医用黏合剂市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 液态医用黏合剂市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国：液态医用黏合剂市场

第十六章 中国：液态医用黏合剂市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • Arkema SA
  • Ashland Global Holdings Inc.
  • Avery Dennison Corporation
  • Dow Inc.
  • Eloquest Healthcare, Inc. by Ferndale Pharma Group, Inc.
  • Evonik Industries AG
  • HB Fuller Company
  • Henkel AG & Co. KGaA
  • Nitto Denko Corporation
  • Panacol-Elosol GmbH
  • Permabond LLC
  • Scapa Group plc
Product Code: MRR-535C6291840B

The Liquid Medical Adhesives Market was valued at USD 12.29 billion in 2025 and is projected to grow to USD 13.12 billion in 2026, with a CAGR of 7.35%, reaching USD 20.21 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 12.29 billion
Estimated Year [2026] USD 13.12 billion
Forecast Year [2032] USD 20.21 billion
CAGR (%) 7.35%

Explore how advances in polymer chemistry and clinical priorities are redefining the role of liquid medical adhesives across care pathways and device ecosystems

Liquid medical adhesives are emerging as essential enablers across modern healthcare pathways, bridging gaps between device design, wound management, and patient-centric care. These chemistries deliver rapid adhesion, conformability to skin and medical substrates, and formulations tuned for biocompatibility, making them well suited for applications where sutureless closure, device fixation, and secure wearable interfaces matter. Advances in polymer science, surface chemistry, and adhesive curing processes have expanded the functional envelope, enabling adhesives to perform reliably under moisture, movement, and extended wear conditions.

Clinicians and device developers increasingly prioritize adhesives that reduce procedure time, lower infection risk, and improve cosmetic outcomes. Consequently, innovation has trended toward formulations that balance shear and peel strength with gentle removal profiles and reduced skin irritation. Regulatory scrutiny has intensified in parallel, prompting manufacturers to invest in robust biocompatibility testing, adhesive-device compatibility assessments, and clinical evidence demonstrating safety and performance.

From an operational perspective, adhesives are influencing care delivery beyond the hospital. The growth of ambulatory procedures, home-based wound care, and wearable therapeutic systems demands adhesives that are simple to apply, provide consistent performance in non-sterile environments, and integrate with remote monitoring. As a result, the technology roadmap now reflects a convergence of material science, user-centered design, and regulatory strategy that positions liquid medical adhesives as a critical component of next-generation medical device ecosystems.

Understand the converging forces of material innovation, clinical workflow evolution, and sustainability that are reshaping liquid medical adhesives for modern healthcare demands

The landscape for liquid medical adhesives is undergoing transformative shifts driven by technological innovation, evolving clinical workflows, and heightened patient expectations. Emerging chemistries, including more sophisticated acrylic systems, cyanoacrylate derivatives, and silicone-based formulations, are enabling adhesives that combine immediate fixation with gentler removal, thereby expanding their suitability across delicate skin types and chronic wound populations. Concurrently, integration with smart wearables and drug delivery patches has created new functional requirements for adhesives to support sensor fidelity, breathability, and controlled wear times.

Health systems are also recalibrating procedural pathways toward minimally invasive and outpatient care, which elevates the importance of adhesive solutions that reduce time in clinic and simplify postoperative management. This shift is complemented by increasing adoption of remote patient monitoring, wherein adhesives must maintain adhesion under day-to-day activities while preserving skin integrity. Supply chain resilience and sustainability considerations are further shaping formulation and packaging choices, prompting manufacturers to explore recyclable substrates, reduced solvent footprints, and streamlined logistics.

Regulatory and reimbursement environments are adjusting to these changes. Manufacturers now face expectations for higher levels of clinical evidence and post-market surveillance, which in turn incentivizes partnerships between adhesive suppliers, device OEMs, and clinical investigators. Altogether, these forces are driving a more integrated, performance-driven market where material innovation, clinical validation, and end-user usability determine competitive differentiation.

Examine how recent U.S. tariff adjustments are prompting strategic sourcing shifts, cost management measures, and resilience planning across adhesive value chains

Recent tariff developments and trade policy decisions in the United States have introduced a new vector of commercial risk and operational complexity for companies sourcing raw materials and finished adhesive products. Tariff adjustments affect upstream polymer suppliers, specialty monomer producers, and ancillary components such as primers and packaging materials. As a result, procurement teams are reassessing sourcing strategies, including nearshoring, multi-supplier qualification, and renegotiated framework agreements to mitigate margin pressure and delivery uncertainty.

In response, manufacturers are implementing a variety of cost-containment and resilience measures. These include optimizing bill-of-materials for lower-cost alternatives where regulatory impact is minimal, increasing inventory buffers for critical components, and accelerating qualification of alternative supply nodes. At the same time, companies are enhancing cost-transparency measures across the value chain to quantify the direct and indirect impacts of tariff changes on pricing strategies and customer contracts.

Strategic responses also emphasize regulatory alignment and risk management. Organizations are combining tariff scenario planning with regulatory pathway assessments to ensure that any substitution of raw materials or change of manufacturing location does not compromise compliance. The result is a more disciplined approach to supplier diversification, contractual safeguards, and long-term sourcing roadmaps that balance commercial agility with product integrity and patient safety.

Discover how product chemistry, clinical application, end-user priorities, and distribution pathways intersect to create differentiated opportunities in liquid medical adhesives

Segmentation reveals where clinical need, material performance, and distribution logistics intersect to create differentiated opportunities. Based on product type, innovation prioritizes acrylic adhesives for broad adhesion profiles, cyanoacrylate adhesives for rapid tissue bonding, hydrocolloid adhesives for wound exudate management, polyurethane adhesives for extensibility and robustness, and silicone adhesives for gentle skin contact and long-wear comfort. These material distinctions influence formulation pathways and shape which applications each product class best serves.

Based on application, the adhesive requirements vary substantially. Catheter fixation demands secure, low-profile bond lines that tolerate patient movement, while drug delivery patches require adhesives that maintain adhesion without compromising drug permeation and sensor contact. Electrode fixation prioritizes consistent skin contact and electrical conduction stability, ostomy appliances need adhesives that can sustain adhesion over irregular surfaces and extended wear, and surgical wound closure applications demand precise bonding performance with validated biocompatibility.

Based on end user, performance and procurement priorities shift. Ambulatory surgical centers favor solutions that reduce procedure time and simplify inventory, home healthcare emphasizes ease-of-use and patient comfort for non-clinical application, hospitals and clinics require robust evidence of performance under diverse patient populations, and research laboratories demand quality-assured materials suitable for testing and innovation. Based on distribution channel, manufacturers must tailor commercial strategies to direct sales relationships for bundled device-adherent systems, distributor partnerships for scale and reach, online sales for convenience and rapid replenishment, and retail pharmacies where consumer-oriented products must meet shelf-ready packaging and regulatory labeling expectations.

Taken together, these segmentation lenses clarify how product chemistry, clinical use case, end-user workflows, and distribution pathways coalesce to shape go-to-market strategies and R&D prioritization.

Assess how regional regulatory regimes, care infrastructure, and procurement preferences in the Americas, EMEA, and Asia-Pacific shape adoption and commercialization strategies

Regional dynamics underscore how regulatory regimes, healthcare infrastructure, and local procurement preferences drive divergent adoption trajectories. In the Americas, demand is shaped by a mix of advanced hospital systems, high ambulatory procedure volumes, and a growing emphasis on home-based care. These conditions favor adhesives that demonstrate clear clinical benefits in reducing procedure time and improving patient comfort, while commercial models often emphasize direct engagement with healthcare providers and centralized distribution networks.

In Europe, the Middle East & Africa, regulatory rigor, varied reimbursement frameworks, and heterogeneous care settings lead to differentiated product adoption. Western European markets often require extensive clinical evidence and adherence to stringent quality systems, whereas markets within the broader region may prioritize cost-effective solutions and adaptable distribution models. Manufacturers operating in this region must navigate complex regulatory pathways and design modular commercial approaches that reflect both high-compliance markets and price-sensitive environments.

In the Asia-Pacific region, rapid healthcare infrastructure expansion, rising outpatient procedures, and an increasing focus on medical device innovation create substantial demand for versatile adhesive solutions. Local manufacturing capabilities and government-driven initiatives to enhance domestic production can influence sourcing and partnership strategies. Across these regions, companies will need to align regulatory preparedness, localized clinical evidence generation, and tailored commercial models to capture opportunities while managing operational complexity.

Evaluate how material innovation, regulatory expertise, and strategic partnerships create competitive advantage and define leadership in the liquid medical adhesive sector

Competitive dynamics are driven by a blend of material innovation, vertical integration, and strategic partnerships across medical device OEMs, specialty adhesive manufacturers, and contract manufacturing organizations. Leading players differentiate through proprietary chemistries that balance adhesive strength with skin gentleness, scale-efficient manufacturing platforms that support consistent quality, and regulatory experience that accelerates clinical adoption. Strategic collaborations with device makers and clinical research partners are increasingly common, enabling co-development of adhesive-device assemblies and evidence packages for targeted applications.

Apart from core chemistry and regulatory capabilities, companies that excel invest in application-specific testing facilities, human factors research, and real-world performance studies. These investments build commercial credibility and reduce adoption friction among clinicians. Firms also explore downstream value-adds such as customized application systems, pre-applied adhesive interfaces on medical devices, and integrated supply solutions that bundle adhesives with device delivery kits. Mergers, acquisitions, and licensing agreements remain viable routes to expand technology portfolios and geographic reach, particularly where local regulatory expertise or production capacity is a differentiator.

Market leaders focus on operational excellence, reproducible quality systems, and clear post-market surveillance processes. Equally important is the ability to articulate clinical and economic value to procurement stakeholders, demonstrating how adhesive-enabled workflows reduce procedure time, lower complication rates, or improve patient satisfaction. This combination of technical strength and commercial clarity defines competitive advantage in the evolving adhesive landscape.

Adopt a pragmatic roadmap that blends material innovation, resilient sourcing, and accelerated clinical validation to capture sustainable growth in adhesive-enabled healthcare applications

Leaders should prioritize a three-pronged approach: innovate across materials and user experience, fortify supply chain resilience, and accelerate clinical validation. Investing in advanced chemistries that reconcile strong adhesion with atraumatic removal will address the most pressing clinical pain points and open new application areas. Simultaneously, design efforts should incorporate patient-centered considerations such as breathability, hypoallergenicity, and compatibility with sensors to ensure broad usability across ambulatory and home-care settings.

On the operational front, diversify sourcing strategies to reduce exposure to single-source suppliers and tariff-driven cost shocks. Establish dual-source qualifications, nearshore manufacturing options, and strategic inventory optimization to maintain service levels without compromising product integrity. Parallel to these actions, embed regulatory risk management into the early stages of product development, ensuring that material substitutions, manufacturing changes, or new packaging formats are validated through targeted biocompatibility and human factors studies.

Finally, accelerate clinical evidence generation through pragmatic trials and real-world evidence initiatives that validate value propositions for clinicians and procurement teams. Use these data to craft compelling health economic narratives that resonate with payers and hospital administrators. Pursue collaborative commercialization models with device OEMs and healthcare providers that align incentives and streamline adoption. Taken together, these actions will strengthen market positioning, reduce operational vulnerability, and support sustainable growth.

Learn how a multi-source methodology combining technical literature, regulatory analysis, and stakeholder interviews produced a robust and reproducible assessment of the adhesive landscape

The research underpinning this analysis combined a systematic review of publicly available scientific literature, regulatory filings, and patent landscapes with structured interviews and primary discussions across the adhesive and medical device ecosystem. Technical literature provided context on polymer chemistries, curing mechanisms, and biocompatibility testing standards, while regulatory documents helped map approval pathways and post-market surveillance expectations in major jurisdictions.

Primary insights were derived from interviews with a cross-section of stakeholders, including clinicians, device engineers, procurement leaders, and manufacturing specialists. These discussions illuminated practical performance requirements, procurement criteria, and operational constraints that influence selection and deployment of adhesive solutions. In addition, supply chain and trade policy analyses were incorporated to contextualize sourcing risks and tariff-related impacts on component availability.

Throughout the research process, findings were triangulated across multiple evidence streams to ensure robustness. Where qualitative differences emerged, they were explored through follow-up interviews and comparison with regulatory precedent. The methodology emphasized reproducibility and transparency in evidence synthesis, enabling readers to understand the provenance of conclusions and the boundaries of inference for strategic decision-making.

Synthesize the strategic imperative that technical excellence, clinical evidence, and resilient operations must align to realize the full potential of liquid medical adhesives

Liquid medical adhesives are poised to play an increasingly central role in modern healthcare by enabling sutureless closure, secure device fixation, and comfortable wearable interfaces. Advances in material science and clinical adoption patterns are converging to expand application breadth across catheter fixation, drug delivery patches, electrode fixation, ostomy appliances, and surgical wound closure. Meanwhile, end-user shifts toward ambulatory and home-based care are amplifying the need for adhesives that perform reliably outside traditional clinical environments.

Operational pressures such as tariffs, supply chain volatility, and regulatory expectations are prompting manufacturers to adopt more disciplined sourcing and evidence-generation strategies. Success will depend on the ability to combine differentiated chemistries with rigorous clinical validation and adaptive commercial models that reflect regional regulatory and reimbursement realities. Companies that invest in integrated product development, resilient manufacturing networks, and clear value communication will be best positioned to translate technological promise into clinical and commercial outcomes.

In sum, the adhesive sector offers tangible opportunities for innovation and growth, but realizing them will require coordinated action across R&D, regulatory, supply chain, and commercial functions. The most successful organizations will be those that align technical excellence with pragmatic deployment strategies to meet the evolving needs of clinicians, patients, and healthcare systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Liquid Medical Adhesives Market, by Product Type

  • 8.1. Acrylic Adhesives
  • 8.2. Cyanoacrylate Adhesives
  • 8.3. Hydrocolloid Adhesives
  • 8.4. Polyurethane Adhesives
  • 8.5. Silicone Adhesives

9. Liquid Medical Adhesives Market, by Application

  • 9.1. Catheter Fixation
  • 9.2. Drug Delivery Patches
  • 9.3. Electrode Fixation
  • 9.4. Ostomy Appliances
  • 9.5. Surgical Wound Closure

10. Liquid Medical Adhesives Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Home Healthcare
  • 10.3. Hospitals & Clinics
  • 10.4. Research Laboratories

11. Liquid Medical Adhesives Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
  • 11.3. Online Sales

12. Liquid Medical Adhesives Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Liquid Medical Adhesives Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Liquid Medical Adhesives Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Liquid Medical Adhesives Market

16. China Liquid Medical Adhesives Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 3M Company
  • 17.6. Arkema S.A.
  • 17.7. Ashland Global Holdings Inc.
  • 17.8. Avery Dennison Corporation
  • 17.9. Dow Inc.
  • 17.10. Eloquest Healthcare, Inc. by Ferndale Pharma Group, Inc.
  • 17.11. Evonik Industries AG
  • 17.12. H.B. Fuller Company
  • 17.13. Henkel AG & Co. KGaA
  • 17.14. Nitto Denko Corporation
  • 17.15. Panacol-Elosol GmbH
  • 17.16. Permabond LLC
  • 17.17. Scapa Group plc

LIST OF FIGURES

  • FIGURE 1. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL LIQUID MEDICAL ADHESIVES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES LIQUID MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA LIQUID MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY ACRYLIC ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY ACRYLIC ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY ACRYLIC ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY HYDROCOLLOID ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY HYDROCOLLOID ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY HYDROCOLLOID ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY POLYURETHANE ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY POLYURETHANE ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY POLYURETHANE ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY SILICONE ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY SILICONE ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY SILICONE ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY CATHETER FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY CATHETER FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY CATHETER FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DRUG DELIVERY PATCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DRUG DELIVERY PATCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DRUG DELIVERY PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY ELECTRODE FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY ELECTRODE FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY ELECTRODE FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY OSTOMY APPLIANCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY OSTOMY APPLIANCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY OSTOMY APPLIANCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY SURGICAL WOUND CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY SURGICAL WOUND CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY SURGICAL WOUND CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS LIQUID MEDICAL ADHESIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. GCC LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GCC LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. GCC LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. GCC LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. GCC LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. G7 LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. G7 LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. G7 LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. G7 LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. G7 LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. NATO LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. NATO LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. NATO LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. NATO LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. NATO LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL LIQUID MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. UNITED STATES LIQUID MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. UNITED STATES LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. UNITED STATES LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. CHINA LIQUID MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 136. CHINA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. CHINA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. CHINA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA LIQUID MEDICAL ADHESIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)